 CHARLESTON, S.C., March 22, 2021 GLOBE NEWSWIRE -- Aeterna Zentaris Inc. NASDAQ: AEZS TSX: AEZS Aeterna or the Company, a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that on March 22, 2021, it received notice from The Nasdaq Stock Market LLC Nasdaq that the Company has regained compliance with the minimum 1.00 bid price per share requirement under Nasdaqs Listing Rule 5550a2. 